This study describes a widespread variation in medication adherence, pharmacy cost sharing, and medical spending. Increased cost sharing may decrease adherence and increase total diabetes spending.
Wes Yin, PhD
Advertisement
Articles by Wes Yin, PhD
This study measured the value of survival gains attributable to the introduction of 3 novel therapies for myelodysplastic syndromes.
Advertisement
Latest Updated Articles
- The Value of Survival Gains in Myelodysplastic Syndromes
Published: January 16th 2017 | Updated:
- The Relationship Between Adherence and Total Spending Among Medicare Beneficiaries With Type 2 Diabetes
Published: April 19th 2017 | Updated:
Advertisement
Advertisement
